🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Don't miss out! At the Courage and Innovation Symposium, gain detailed insights into medical and surgical therapies for complex cardiovascular disease. Register now here: courageandinnovation.com #HeartFailure #Cardiology #CardioTwitter

NEW HFSA Endorsed Meeting: 2025 Courage and Innovation Symposium Dates: February 8, 2025 Location: In person, David Rubenstein Forum, University of Chicago CE Credits: 7 Chairs: Ben Chung, MD and Christopher T. Salerno, MD Learn more >> hfsa.org/event/2025-cou… #CIS2025

On January 13, the University of Chicago Heart and Vascular Center achieved a groundbreaking milestone by becoming the first hospital in Illinois—and the Midwest—to implant the BrioVAD system as part of the INNOVATE Trial.

Just 5 days until the best #heartfailure #hearttransplant conference in the Midwest! Still open for registration to cardiologists, trainees, APPs, pharmacists, and anyone else interested in learning about the cutting edge in HF + advanced options mgmt. courageandinnovation.com

UChicago Medicine faculty are leading the way in heart failure therapeutics at #THT2025! From late-breaking science to cutting-edge technology, our experts are driving the conversation on the future of cardiac care. Date: Feb 11-13 Stay tuned for details on our featured sessions.

Dr. Anthony Kanelidis (Anthony Kanelidis, MD ) presents The RV-Protection Study at #THT2025. This research explores strategies to mitigate RV dysfunction following LVAD implantation. Co-authored with Jon Grinstein MD Date: Feb 13 Time: 7:36 AM ET Location: Ensemble E-F – Level 2

🚨RHF a significant morbidity after LVAD🚨 Come learn the results of the RV-Protection Study, led by Anthony Kanelidis, MD & Jon Grinstein MD, evaluating mitigation of RHF in the early post-operative LVAD course! #THT2025 UChicagoCardio 🗓️ Feb 13 ⏲️7:36 AM ET Ensemble E-F – Level 2

#THT2025 is in full swing, and UChicago Medicine experts are gearing up for key discussions on heart failure therapeutics, late-breaking science, and emerging technology. Our leaders will be presenting Feb 12-13—don’t miss these important conversations!

Chief fellow University of Chicago Cardiology Fellowship Dr. Mary Acosta presenting on the single-center RCT she led UChicagoCardio Patients randomized to SGLT2i after LVAD implantation had significantly lower LVEDD compared to usual care at 6-months #THT2025

Fresh from #THT2025! Dr. Anthony Kanelidis (Anthony Kanelidis, MD) & Dr. Jonathan Grinstein (Jon Grinstein MD) just presented the RV-Protection Study, and now the full research is available in Journal of Cardiac Failure. Their study details how a novel, up-front post-operative clinical strategy reduced

🚨New science alert! HM3 LVADs are associated w/hemodynamic related events like RVF. In this prospective RCT, pts who received a novel RV protection strategy upfront post-LVAD implant had better outcomes & less RVF. #THT2025 🔗: bit.ly/3CEDDN7

Celebrating Heart Failure Awareness Week by looking back at a year of innovation in UChicago Medicine’s Advanced Heart Failure Program. #HFWeek2025

2025 is off to a historic start! UChicago Medicine continues to push the boundaries of heart failure treatment. #HFWeek2025

Excited for the future of energetic modeling in heart failure. PAC Dynamic: Predicting Heart Failure Progression for Precision Care polsky.uchicago.edu/2025/02/12/pac… via Polsky Center at the University of Chicago

Not sure you are doing all that you should do in new onset #HFrEF? Now in JACC Journals #JACCHF: 5 pivotal questions re: eval of new HFrEF based on guidelines and emerging data! @UTSWheart Mark Drazner Michelle Dimza Cliff Pruett Maryjane Farr MD MSc, FACC FAST FHFSA FAHA jacc.org/doi/10.1016/j.…

🔥🔥 Read all about Donor Selection for Heart Transplantation in 2025 🫀🫀 JACC Journals #JACCHF by #RashmiJain #EvanKransdorf Jennifer Cowger Valluvan Jeevanandam, MD #JonKobashigawa 👉 jacc.org/doi/full/10.10…

2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock: A Report of the American College of Cardiology Solution Set Oversight Committee | JACC jacc.org/doi/10.1016/j.…

HFmrEF/HFpEF can’t wait Rx the 3 🏛️ SGLTi + nsMRA + GLP-1 RA (if obesity) The optimal strategy is simultaneous or rapid sequence initiation to all eligible patients, without delay Gregg Fonarow MD Javed Butler Duke Clinical Research Institute JAMA Cardiology jamanetwork.com/journals/jamac…

The 1st annual Chicago Hemodynamic Forum was a success! Check out our special report in Circ: Heart Failure reviewing the inaugural meeting ahajournals.org/doi/10.1161/CI… We're busy planning for year 2 - agenda coming shortly Save-the-date: Friday, November 14th in Chicago, IL! Chicago Hemodynamic Forum

Looking forward to The ISHLT 2025 in Boston! Excited to present our experience with bloodless transplantation abstractsonline.com/pp8/#!/20756/p… UChicagoCardio UChicagoHVC UChicago Medicine Jon Grinstein MD Gene Kim Mark Belkin Ben Chung MD Anthony Kanelidis, MD Leo Gozdecki, DO